224 related articles for article (PubMed ID: 28474564)
1. Substance P Regulation in Epilepsy.
Chi G; Huang Z; Li X; Zhang K; Li G
Curr Neuropharmacol; 2018; 16(1):43-50. PubMed ID: 28474564
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of substance P transport across the blood-brain barrier.
Chappa AK; Audus KL; Lunte SM
Pharm Res; 2006 Jun; 23(6):1201-8. PubMed ID: 16729222
[TBL] [Abstract][Full Text] [Related]
3. Involvement of substance P and the NK-1 receptor in pancreatic cancer.
Muñoz M; Coveñas R
World J Gastroenterol; 2014 Mar; 20(9):2321-34. PubMed ID: 24605029
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of substance P receptor expression by calcitonin gene-related peptide, a possible cooperative action of two neuropeptides involved in airway inflammation.
Wu H; Guan C; Qin X; Xiang Y; Qi M; Luo Z; Zhang C
Pulm Pharmacol Ther; 2007; 20(5):513-24. PubMed ID: 16777450
[TBL] [Abstract][Full Text] [Related]
5. Cancer progression and substance P.
Coveñas R; Muñoz M
Histol Histopathol; 2014 Jul; 29(7):881-90. PubMed ID: 24535838
[TBL] [Abstract][Full Text] [Related]
6. The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.
Munoz M; Covenas R; Esteban F; Redondo M
J Biosci; 2015 Jun; 40(2):441-63. PubMed ID: 25963269
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between neurokinin receptor signaling and neuroinflammation in neurological disorders.
Eapen PM; Rao CM; Nampoothiri M
Rev Neurosci; 2019 Apr; 30(3):233-243. PubMed ID: 30260793
[TBL] [Abstract][Full Text] [Related]
8. Alcohol dependence potentiates substance P/neurokinin-1 receptor signaling in the rat central nucleus of amygdala.
Khom S; Steinkellner T; Hnasko TS; Roberto M
Sci Adv; 2020 Mar; 6(12):eaaz1050. PubMed ID: 32206720
[TBL] [Abstract][Full Text] [Related]
9. The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.
Muñoz M; González-Ortega A; Salinas-Martín MV; Carranza A; Garcia-Recio S; Almendro V; Coveñas R
Int J Oncol; 2014 Oct; 45(4):1658-72. PubMed ID: 25175857
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of substance P and NK-1 receptor in vascular anomalies.
Ortiz-Prieto A; Bernabeu-Wittel J; Zulueta-Dorado T; Lorente-Lavirgen AI; Muñoz M
Arch Dermatol Res; 2017 Mar; 309(2):97-102. PubMed ID: 27988892
[TBL] [Abstract][Full Text] [Related]
11. Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study.
Myöhänen TT; Venäläinen JI; Garcia-Horsman JA; Männistö PT
Neuroscience; 2008 Jun; 153(4):1177-89. PubMed ID: 18455882
[TBL] [Abstract][Full Text] [Related]
12. The NK-1 receptor: a new target in cancer therapy.
Muñoz M; Rosso M; Coveñas R
Curr Drug Targets; 2011 Jun; 12(6):909-21. PubMed ID: 21226668
[TBL] [Abstract][Full Text] [Related]
13. Immunolocalization of substance P and NK-1 receptor in Hofbauer cells in human normal placenta.
Muñoz M; Carranza A; Pavón A; Anderson G; Coveñas R
Microsc Res Tech; 2013 Dec; 76(12):1310-3. PubMed ID: 24155270
[TBL] [Abstract][Full Text] [Related]
14. Focal inhibitory interneuron loss and principal cell hyperexcitability in the rat hippocampus after microinjection of a neurotoxic conjugate of saporin and a peptidase-resistant analog of Substance P.
Martin JL; Sloviter RS
J Comp Neurol; 2001 Jul; 436(2):127-52. PubMed ID: 11438920
[TBL] [Abstract][Full Text] [Related]
15. Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.
Lévesque M; Wallman MJ; Parent R; Sík A; Parent A
Neurosci Res; 2007 Mar; 57(3):362-71. PubMed ID: 17134780
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of NK-1 receptor and Substance P in human normal placenta.
Muñoz M; Pavón A; Rosso M; Salinas MV; Pérez A; Carranza A; González-Ortega A
Placenta; 2010 Jul; 31(7):649-51. PubMed ID: 20430440
[TBL] [Abstract][Full Text] [Related]
17. Neurokinin-1 receptor: a new promising target in the treatment of cancer.
Muñoz M; Coveñas R
Discov Med; 2010 Oct; 10(53):305-13. PubMed ID: 21034671
[TBL] [Abstract][Full Text] [Related]
18. Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells.
Okada T; Hirayama Y; Kishi S; Miyayasu K; Hiroi J; Fujii T
Inflamm Res; 1999 May; 48(5):274-9. PubMed ID: 10391116
[TBL] [Abstract][Full Text] [Related]
19. A new frontier in the treatment of cancer: NK-1 receptor antagonists.
Muñoz M; Rosso M; Coveñas R
Curr Med Chem; 2010; 17(6):504-16. PubMed ID: 20015033
[TBL] [Abstract][Full Text] [Related]
20. In vivo mapping of substance P receptors in brains of laboratory animals by high-resolution imaging systems.
Haneda E; Higuchi M; Maeda J; Inaji M; Okauchi T; Ando K; Obayashi S; Nagai Y; Narazaki M; Ikehira H; Nakao R; Zhang MR; Suzuki K; Suzuki H; Suhara T
Synapse; 2007 Apr; 61(4):205-15. PubMed ID: 17230554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]